On 21 October, a consortium consisting of China Resources Group and Macquarie Capital became the new majority shareholders of GenesisCare.
This is the fourth private equity investor that GenesisCare has had since it was formed. The consortium will work alongside doctors and management to support growth plans in Australia, the UK and Spain. Management and doctors will control the Board and in agreement with the consortium the company will remain Australian based with the same Executive Management Team and with the same strategy of providing high-quality care for patients.Read more
GenesisCare, the largest private provider of radiotherapy services in Australia and the UK, held a very successful contouring and planning event; enabling more clinical oncologists to deliver or refer patients for Stereotactic Ablative Body Radiotherapy (SABR).
Clinical oncologists (covering a variation of body sites) from across Portsmouth, Southampton and Windsor took the opportunity to be part of this highly interactive, educational and networking event.Read more
Challenge to increase lung cancer five-year survival rates to 25% by 2025
A new report by the UK Lung Cancer Coalition of charities and doctors is challenging governments to increase five-year survival rates to 25% by 2025. If achieved, this will result in at least 4,000 deaths prevented within five years of diagnosis each year - or over the UK 11,000 deaths prevented per year overall.Read more
GenesisCare is thrilled to be a Premier Partner of the College of Radiographers Industry Partnership Scheme (CoRIPS). It was lovely to meet Richard Evans (Society CEO) at our Maidstone centre, and we look forward to developing our partnership.Read more